Nanomaterial could enhance diabetes treatment

Conventional treatments for diabetes can increase the risk of neurological problems, an under-researched side effect. U.S. National Science Foundation-supported scientists based at The Ohio State University developed a nanomaterial that binds insulin to a group of amino acids that includes antioxidants. The nanomaterial improved glucose consumption, leading to better brain function.